Precision & depth
With 20 years of experience, IASON consulting provides the depth and precision the required to compile an IMPD for EU regulatory authorities.
Product profile
We focus on providing a clear risk-benefit assessment based on the available data. This assessment plays a pivotal role in regulatory evaluations, determining whether the product's potential benefits outweigh its risks in the proposed clinical trials.
Safety and efficacy
The dossier requires the author to integrate relevant non-clinical (preclinical) and clinical data. This includes studies supporting the investigational product's safety, efficacy, and pharmacology.
Risk-benefit
We furnish comprehensive information about the investigational medicinal product's composition, source, quality, and method of manufacture. This ensures the IMP meets all EU quality standards.
IMPD writing service
IASON consulting offers a writing and review service for IMPDs. Leveraging deep knowledge and insights from countless successful submissions, we ensure your IMPD not only stands up to regulatory scrutiny but also lays a robust foundation for your clinical trial endeavors in Europe.
Two decades of experience
Countless successful IMPDs prepared
Consulting on best approach